Abstract
The term “cognitive enhancement” distinguishes one area of mental capacities: the cognitive capacities in contrast to non-cognitive capacities. The widespread use of this term within the ethical debate about pharmacological enhancement suggests that the enhancement of cognitive properties raises particular ethical questions that are different from the ethical questions raised by other kinds of neuro-enhancement. Or, the suggestion is at least that cognitive enhancement raises the ethical questions with a higher intensity. This article examines whether these suggestions are correct. The purpose of this article is therefore not to examine the ethical questions raised by cognitive enhancement but to examine the question as to whether the ethical problems of cognitive and non-cognitive enhancement are significantly different and, therefore, whether the concentration on cognitive enhancement within the bioethical debate is justified. The result of this examination is: the suggestion is not correct, the ethical questions raised by the different forms of pharmacological enhancement are in most respects equal or similar, and the concentration on cognitive enhancement is largely not justified.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
To be more precise we should speak of “psycho-enhancement” or “mental enhancement” because the aim of these measures is not to improve neurons but mental or psychological properties. Moreover, the nervous system is the basis for more than our mental properties. However, “psycho-enhancement” and “mental enhancement” are not widely used terms in this discussion.
- 2.
President’s Council (2003, 305): “What is to be particularly feared about the increasingly common and casual use of mind-altering drugs, then, is not that they will induce us to dwell on happiness at the expense of other human goods, but that they will seduce us into resting content with a shallow and factitious happiness.” Cf. the considerations of Christoph Rehmann-Sutter on “authentic happiness”: Rehmann-Sutter (2008). Cf. also Krämer (2009, 213).
- 3.
Even authors who are not generally critical of neuro-enhancement consider this as a big problem; cf. e.g. Schöne-Seifert (2006, 281).
References
Asendorpf JB (2009) Persönlichkeitspsychologie – für Bachelor. Springer, Berlin/Heidelberg
Bandura A (1994) Self-efficacy. The exercise of control. Palgrave Macmillan, New York
Bette K-H, Schimank U (2006) Doping im Hochleistungssport. Anpassung durch Abweichung, 2nd edn. Suhrkamp, Frankfurt am Main
Biedermann F (2010) Argumente für und wider das Cognitive Enhancement. Eine kritische Kurzübersicht. Ethik Med 22:317–319
Boldt J, Maio G (2009) Neuroenhancement. Vom technizistischen Missverständnis geistiger Leistungsfähigkeit. In: Müller O, Clausen J, Maio G (eds) Das technisierte Gehirn. Neurotechnologien als Herausforderung für Ethik und Anthropologie. Mentis, Paderborn, pp 383–397
Bostrom N, Sandberg A (2009) Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics 15:311–341
Brehm M (2001) Emotionen in der Arbeitswelt. Theoretische Hintergründe und praktische Einflussnahme. Arbeit – Zeitschrift für Arbeitsforschung, Arbeitsgestaltung und Arbeitspolitik 10:205–218
Cakic V (2009) Smart drugs for cognitive enhancement. Ethical and pragmatic considerations in the era of cosmetic neurology. J Med Ethics 35:611–615
DAK (2009) DAK-Gesundheitsreport 2009. Analyse der Arbeitsunfähigkeitsdaten. Syllabication: Schwertpunktthema Doping am Arbeitsplatz. www.dak.de/content/filesopen/Gesundheitsreport_2009.pdf. Last accessed 26 June 2012
Dolan RJ (2002) Emotion, cognition, and behavior. Science 298:1191–1194
Fachinformation des Arzneimittel-Kompendium der Schweiz (2009) Ritalin®/-SR/-LA Last information: May 2011. www.kompendium.ch/MonographieTxt.aspx?lang=de&MonType=fi;
Förstl H (2009) Neuro-Enhancement. Nervenarzt 80:840–846
Freedman C (1998) Aspirin for the mind? Some ethical worries about psychopharmacology. In: Parens E (ed) Enhancing human traits. Ethical and social implications. Georgetown University Press, Washington, DC, pp 135–150
Gesang B (2007) Die Perfektionierung des Menschen. deGruyter, Berlin
Goleman D, Boyatzis R, McKee A (2002) Primal leadership. Learning to lead with emotional intelligence. Harvard Business School Press, Boston
Goodman R (2010) Cognitive enhancement, cheating, and accomplishment. Kennedy Inst Ethics J 20:145–160
Hänze M (2009) Denken und Gefühl. Wechselwirkung zwischen Emotion und Kognition im Unterricht. Beltz, Weinheim/Basel
Heinz A, Kipke R, Heimann H, Wiesing U (2012) Cognitive neuro-enhancement – false assumptions in the ethical debate. J Med Ethics 38:372–375
Hyman SE (2011) Cognitive enhancement: promises and perils. Neuron 69:595–598
Juengst ET (1998) What does enhancement mean? In: Parens E (ed) Enhancing human traits. Ethical and social implications. Georgetown University Press, Washington, DC
Kipke R (2011) Besser werden. Eine ethische Untersuchung zu Selbstformung und Neuro-Enhancement. Mentis, Paderborn
Kramer PD (1997) Listening to Prozac. Penguin, New York
Krämer F (2009) Neuro-Enhancement von Emotionen. Zum Begriff emotionaler Authentizität. In: Schöne-Seifert B, Talbot D, Opolka U, Ach JS (eds) Neuro-Enhancement. Ethik vor neuen Herausforderungen. Mentis, Paderborn, 189–217
Lenk C (2002) Therapie und Enhancement. Ziele und Grenzen der modernen Medizin. Lit Verlag, Münster
Lieb K (2010) Hirndoping. Warum wir nicht alles schlucken sollten. Artemis & Winkler, Mannheim
Persson I, Savulescu J (2008) The perils of cognitive enhancement and the urgent imperative to enhance the moral character of humanity. J Appl Philos 25:162–177
President’s Council on Bioethics (2003) Beyond therapy. Biotechnology and the pursuit of happiness. A report of the president’s council on bioethics. University of Chicago Press, New York/Washington, DC
Rehmann-Sutter C (2008) Authentisches Glück? Ethische Überlegungen zu Neuro-Enhancement. In: Maio G, Clausen J, Müller O (eds) Mensch ohne Maß? Reichweite und Grenzen syllabication: anthropologischer Argumente in der biomedizinischen Ethik. Karl Alber, Freiburg/München, pp 242–259
Repantis D, Schlattmann P, Laisney O, Heuser I (2009) Antidepressants for neuro-enhancement in healthy individuals. A systematic review. Poiesis Prax 6:139–174
Sandel M (2007) The case against perfection: ethics in the age of genetic engineering. Harvard University Press, Cambridge, MA/London
Schleim S, Walter H (2007) Cognitive enhancement. Fakten und Mythen. Nervenheilkunde 26:83–87
Schmidt-Felzmann H (2009) Prozac und das wahre Selbst. Authentizität bei psychopharmakologischer enhancement. In: Schöne-Seifert B, Talbot D, Opolka U, Ach JS (eds) Neuro-Enhancement. Ethik vor neuen Herausforderungen. Mentis, Paderborn, pp 143–158
Schöne-Seifert B (2006) Pillen-Glück statt Psycho-Arbeit. Was wäre dagegen einzuwenden? In: Ach JS, Pollmann A (eds) No body is perfect. Baumaßnahmen am menschlichen Körper. Bioethische und ästhetische Aufrisse. Transcript, Bielefeld, pp 279–291
Stier M (2009) Neuro-Enhancement und das Problem der Verantwortung. In: Schöne-Seifert B, Talbot D, Opolka U, Ach JS (eds) Neuro-Enhancement. Ethik vor neuen Herausforderungen. Mentis, Paderborn, pp 277–293
Synofzik M (2006) Kognition à la carte? Der Wunsch nach kognitionsverbessernden Psychopharmaka in der Medizin. Ethik Med 18:37–50
Tangney JP, Baumeister RF, Boone AL (2004) High self-control predicts good adjustment, less pathology, better grades, and interpersonal success. J Pers 72:271–324
Tännsjö T (2009) Ought we to enhance our cognitive capacities? Bioethics 23:421–432
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Kipke, R. (2013). What Is Cognitive Enhancement and Is It Justified to Point Out This Kind of Enhancement Within the Ethical Discussion?. In: Hildt, E., Franke, A. (eds) Cognitive Enhancement. Trends in Augmentation of Human Performance, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6253-4_13
Download citation
DOI: https://doi.org/10.1007/978-94-007-6253-4_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6252-7
Online ISBN: 978-94-007-6253-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)